ImageneBio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $207.9M | $232.2M |
| FY2022 | — | $147.0M | $59.9M |
| FY2023 | — | $-126.1M | $119.9M |
| FY2024 | — | $-160.6M | $12.1M |
| FY2025 | — | $133.1M | $94.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $207.9M | $232.2M |
| FY2022 | — | $147.0M | $59.9M |
| FY2023 | — | $-126.1M | $119.9M |
| FY2024 | — | $-160.6M | $12.1M |
| FY2025 | — | $133.1M | $94.5M |